Mayfair Advisory Group LLC Acquires New Shares in Encompass Health Corporation $EHC

Mayfair Advisory Group LLC bought a new position in shares of Encompass Health Corporation (NYSE:EHC) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 1,785 shares of the company’s stock, valued at approximately $210,000.

Several other large investors also recently modified their holdings of EHC. WPG Advisers LLC bought a new position in shares of Encompass Health during the 1st quarter valued at about $27,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in Encompass Health by 749.0% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock worth $42,000 after buying an additional 367 shares during the period. Employees Retirement System of Texas acquired a new stake in Encompass Health during the 2nd quarter worth approximately $57,000. Parkside Financial Bank & Trust lifted its stake in Encompass Health by 179.5% in the second quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock valued at $59,000 after buying an additional 307 shares in the last quarter. Finally, Park Place Capital Corp bought a new stake in shares of Encompass Health during the second quarter worth $72,000. 97.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on EHC shares. Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Raymond James Financial upgraded Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. KeyCorp raised their price target on shares of Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research note on Tuesday, September 16th. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday. Finally, Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $142.86.

Encompass Health Stock Performance

Shares of EHC stock opened at $116.36 on Thursday. The company has a fifty day moving average price of $120.80 and a two-hundred day moving average price of $119.53. Encompass Health Corporation has a one year low of $87.85 and a one year high of $127.99. The stock has a market cap of $11.71 billion, a P/E ratio of 22.00, a P/E/G ratio of 2.20 and a beta of 0.91. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06.

Encompass Health (NYSE:EHC) last issued its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. The company had revenue of $136.30 million for the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, equities analysts predict that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a dividend of $0.19 per share. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s payout ratio is presently 14.37%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.